Novo Holdings A/S
25 holdingsFiling period: 2026-06-30Current AUM: $1.48Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | EWTX | Edgewise Therapeutics Inc | 5.35M | $217.4M | $213.9M | 14.47% | -- | 2026-06-30 |
| 2 | — | Asml Holding N V | 94.9K | $188.9M | $188.9M | 12.77% | -- | 2026-06-30 |
| 3 | COAG | Hemab Therapeutics Hldgs Inc | 4.18M | $153.6M | $145.5M | 9.84% | -- | 2026-06-30 |
| 4 | BN | Brookfield Corp | 3.50M | $149.5M | $134.4M | 9.09% | -- | 2026-06-30 |
| 5 | MPLT | Maplight Therapeutics Inc | 3.69M | $132.1M | $30.4M | 2.06% | -- | 2026-06-30 |
| 6 | MIRM | Mirum Pharmaceuticals Inc | 1.13M | $131.7M | $93.5M | 6.32% | -200,000 | 2026-06-30 |
| 7 | AVLN | Avalyn Pharmaceuticals Inc | 3.88M | $127.8M | $105.8M | 7.16% | -- | 2026-06-30 |
| 8 | CRM | Salesforce Inc | 393.2K | $61.6M | $98.4M | 6.65% | -- | 2026-06-30 |
| 9 | AVBP | Arrivent Biopharma Inc | 1.50M | $52.1M | $28.8M | 1.95% | -442,142 | 2026-06-30 |
| 10 | ELVN | Enliven Therapeutics Inc | 1.00M | $50.8M | $41.9M | 2.84% | -280,000 | 2026-06-30 |
| 11 | CRNX | Crinetics Pharmaceuticals in | 1.32M | $49.4M | $49.4M | 3.34% | -230,000 | 2026-06-30 |
| 12 | — | Pharvaris N V | 1.40M | $48.4M | $48.4M | 3.27% | -350,000 | 2026-06-30 |
| 13 | FND | Floor & Decor Hldgs Inc | 797.0K | $47.3M | $38.4M | 2.60% | -- | 2026-06-30 |
| 14 | PCVX | Vaxcyte Inc | 800.0K | $46.5M | $50.3M | 3.40% | -60,000 | 2026-06-30 |
| 15 | FDMT | 4D Molecular Therapeutics in | 3.25M | $43.2M | $38.5M | 2.60% | -401,559 | 2026-06-30 |
| 16 | VRDN | Viridian Therapeutics Inc | 2.13M | $39.2M | $48.7M | 3.29% | +135.0K | 2026-06-30 |
| 17 | CLDX | Celldex Therapeutics Inc New | 1.02M | $38.1M | $29.7M | 2.01% | -175,000 | 2026-06-30 |
| 18 | ALMS | Alumis Inc | 1.10M | $31.0M | $7.5M | 0.51% | -- | 2026-06-30 |
| 19 | XENE | Xenon Pharmaceuticals Inc | 485.4K | $29.3M | $17.7M | 1.20% | -- | 2026-06-30 |
| 20 | BABA | Alibaba Group Hldg Ltd | 257.3K | $24.7M | $26.2M | 1.77% | -- | 2026-06-30 |
| 21 | DYN | Dyne Therapeutics Inc | 960.4K | $21.3M | $15.1M | 1.02% | -- | 2026-06-30 |
| 22 | BBOT | Bridgebio Oncology Therapeut | 2.25M | $17.1M | $6.4M | 0.43% | +64.1K | 2026-06-30 |
| 23 | INSM | Insmed Inc | 120.7K | $12.9M | $11.5M | 0.78% | -- | 2026-06-30 |
| 24 | MQ | Marqeta Inc | 441.6K | $7.2M | $8.5M | 0.58% | -- | 2026-06-30 |
| 25 | LNZA | Lanzatech Global Inc | 158.1K | $1.1M | $787K | 0.05% | -- | 2026-06-30 |
← Scroll →